Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Studies Find Biotechnology Anemia Drug Shows Promise in Treating Several Diseases

Article Abstract:

Amgen Inc., Johnson & Johnson, Warren Pharmaceuticals and a variety of independent researchers are looking at new ways to use erythropoietin. The anemia drug shows promise in the treatment of brain damage from stroke, schizophrenia, AIDS-related dementia and nerve diseases.

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Usage, Johnson & Johnson, Erythropoietin, JNJ, Epogen (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Patients in Test Won't Get Drug, Amgen Decides

Article Abstract:

A group of Amgen clinical trial participants who had benefited from an experimental Parkinson's drug are frustrated that the company has forbidden them to continue with the therapy.

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Legal issues & crime, Government regulation (cont), Government regulation, Public affairs, Legal/Government Regulation, Ethics, Laws, regulations and rules, Clinical trials, Drug therapy, Ethical aspects, Licensing, certification and accreditation, Parkinson's disease, Parkinson disease, United States. Food and Drug Administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


In Drug Research, Some Guinea Pigs Are Now Human

Article Abstract:

Pharmaceutical companies are increasingly using quick human trials to gauge a drug's efficacy before committing to long-term studies.

Author: Pollack, Andrew
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Germany, Methods, Pfizer Inc., PFE, Pharmaceutical research, Dana-Farber Cancer Institute Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Product development, Pharmaceutical industry, Amgen Inc., AMGN
Similar abstracts:
  • Abstracts: Sun Life Financial to review its sales commission practices. Royal group ousts top 3 executives
  • Abstracts: Sex and love: The new world. The fine art of letting go. A writer who beat the odds: Hillenbrand battled chronic fatigue to pen a best seller
  • Abstracts: The Oil Market Refuses to Heed Positive News. A Tanker Shortage Contributes to Rising Oil Costs
  • Abstracts: Hybrid-Car Tinkerers Scoff at No-Plug-In Rule. Sure, It's Pragmatic. But Stylish? The Minivan Is Getting a Makeover
  • Abstracts: U.S. Allows Continued Sale Of Abbott Weight-Loss Drug. New York's Pension Fund Files Own Suit Against Merck. $60 Million Deal In Pfizer Suit
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.